Mass spectrometry-based serum peptidome profiling accurately and reliably predicts outcomes of pemetrexed plus platinum chemotherapy in patients with advanced lung adenocarcinoma

BACKGROUND: Although pemetrexed plus cis/carboplatin has become the most effective chemotherapy regimen for patients with advanced lung adenocarcinoma, predictive biomarkers are not yet available, and new tools to identify chemosensitive patients who would likely benefit from this treatment are desp...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lin, Tang, Chuanhao, Xu, Bin, Yang, Lin, Qu, Lili, Li, Liangliang, Li, Xiaoyan, Wang, Weixia, Qin, Haifeng, Gao, Hongjun, He, Kun, Liu, Xiaoqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464620/
https://www.ncbi.nlm.nih.gov/pubmed/28594947
http://dx.doi.org/10.1371/journal.pone.0179000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464620/
https://www.ncbi.nlm.nih.gov/pubmed/28594947
http://dx.doi.org/10.1371/journal.pone.0179000

Ejemplares similares